ストックスクリーナーアプリを入手
2.58
28.33%
-1.02
アフターアワーズ：
2.60
0.02
+0.78%
前日終値:
$3.60
開ける：
$3.59
24時間の取引高:
1.21M
Relative Volume:
1.37
時価総額：
$122.15M
収益：
-
当期純損益:
$-8.99M
株価収益率:
-13.59
EPS:
-0.1898
ネットキャッシュフロー:
$-3.94M
1週間 パフォーマンス:
-15.69%
1か月 パフォーマンス:
-46.80%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$2.33
$3.78
1週間の範囲:
$2.33
$4.205
52週間の値動き範囲:
$2.201
$33.90
Polaryx Therapeutics Inc Stock (PLYX) Company Profile
名前
Polaryx Therapeutics Inc
セクター
電話
201-940-7236
住所
140 EAST RIDGEWOOD AVENUE, PARAMUS
Compare PLYX vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PLYX
Polaryx Therapeutics Inc
|
2.58 | 170.44M | 0 | -8.99M | -3.94M | -0.1898 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Polaryx Therapeutics Inc Stock (PLYX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-27 | 開始されました | Maxim Group | Buy |
Polaryx Therapeutics Inc (PLYX) 最新ニュース
PLYX - Finviz
PLYX Technical Analysis | Trend, Signals & Chart Patterns | POLARYX THERAPEUTICS INC (NASDAQ:PLYX) - ChartMill
Polaryx Therapeutics, Inc. Q1 2026 Financial Results and Pipeline Update: Progress in Rare Pediatric Lysosomal Storage Disorder Therapies - Minichart
Polaryx Therapeutics (NASDAQ: PLYX) narrows loss but flags going concern risk - Stock Titan
Polaryx Therapeutics 1Q 2026: Net income $(2.54M), EPS $(0.05) — 10-Q Summary - TradingView
Polaryx Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Polaryx Therapeutics Awarded Double Honors at the 2026 GHP Healthcare & Pharmaceutical Awards - Quiver Quantitative
Polaryx Therapeutics Receives GHP Magazine’s Healthcare & Pharmaceuticals Awards - The Manila Times
Biotech for rare pediatric lysosomal diseases wins 2 GHP awards - Stock Titan
PLYX Stock Price, Quote & Chart | POLARYX THERAPEUTICS INC (NASDAQ:PLYX) - ChartMill
Number of shareholders of Polaryx Therapeutics, Inc. – NASDAQ:PLYX - TradingView
Polaryx Therapeutics (NASDAQ:PLYX) Shares Down 16.3%What's Next? - MarketBeat
Polaryx Therapeutics, Inc. Financial Disclosures & SEC Filings - TradingView
Technical Analysis of Polaryx Therapeutics, Inc. (NASDAQ:PLYX) - TradingView
PLYX Polaryx Therapeutics highlights rare disease pipeline progress in its newly released quarterly earnings report.Verified Stock Signals - Newser
Polaryx Therapeutics to Participate in National Tay-Sachs & Allied Diseases Association Annual Family Conference - The Manila Times
Polaryx heads to Tay-Sachs family meeting with Phase 2 program - Stock Titan
FDA grants fast track status to Polaryx’s PLX-200 for three rare diseases - Investing.com Nigeria
Polaryx receives U.S. FDA Fast Track Designation for PLX-200 - TipRanks
Polaryx Therapeutics Gets FDA Fast Track Designations for Its Lead Drug Candidate - marketscreener.com
Polaryx Therapeutics receives U.S. FDA fast track designations for all four indications to be evaluated in the Soteria Basket Trial - marketscreener.com
Polaryx Therapeutics Receives U.S. FDA Fast Track Designations for All Four Indications to be Evaluated in the SOTERIA Basket Trial - The Manila Times
FDA fast-tracks Polaryx drug for 4 rare childhood disorders - Stock Titan
Does Polaryx Therapeutics (PLYX) Stock Pay Dividends? (Underperforming) 2026-04-20Real Trader Network - Cổng thông tin điện tử Tỉnh Sơn La
PLYX Should I Buy - Intellectia AI
Polaryx Therapeutics Recognized with Pinnacle Award for Excellence in Pediatric Care - The Manila Times
A rare-disease biotech, Polaryx, just won a pediatric care award - Stock Titan
Number of employees of Polaryx Therapeutics, Inc. – NASDAQ:PLYX - TradingView
What makes Polaryx Therapeutics (PLYX) Stock attractive or not | Price at $5.63, Down 2.26%Breakout Watch - Cổng thông tin điện tử tỉnh Lào Cai
PLYX Stock Price and Chart — NASDAQ:PLYX - TradingView
Polaryx Therapeutics, Inc.Common Stock (NQ: PLYX - The Chronicle-Journal
Polaryx Therapeutics, Inc. News — NASDAQ:PLYX - TradingView
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Polaryx Therapeutics, Inc. (PLYX) stock price, news, quote and history - Yahoo Finance UK
PLYX: Polaryx Therapeutics, Inc.Options Chain - Zacks Investment Research
PLYX Stock Analysis: Polaryx Therapeutics Inc. biotech gains 7.54% to hit 8.13 level - newser.com
Polaryx Therapeutics To Participate In The 25th Annual Needham Virtual Healthcare Conference - Bitget
Polaryx to webcast Needham healthcare presentation on Apr. 16 - Stock Titan
Polaryx Therapeutics Inc (NASDAQ: PLYX)Share Price - intelligentinvestor.com.au
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Harmony Biosciences stock faces pipeline scrutiny amid Polaryx integration challenges and rare disea - AD HOC NEWS
Polaryx Therapeutics: Advancing Innovative Therapies for Rare Pediatric Lysosomal Storage Disorders (LSDs) - Minichart
Polaryx Therapeutics (NASDAQ: PLYX) outlines rare pediatric LSD pipeline - Stock Titan
PLYX: Net loss improved to $9.0M in 2025, but cash only funds operations through Q3 2026 - TradingView
MSN Money - MSN
Polaryx Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Polaryx Therapeutics, Inc.(NasdaqCM: PLYX) added to S&P TMI Index - marketscreener.com
Polaryx Therapeutics (PLYX) Stock Trends and Sentiment 2026 - MarketBeat
FDA grants fast track status to Polaryx’s PLX-200 for CLN2 disease By Investing.com - Investing.com South Africa
Polaryx Therapeutics (PLYX) FDA Approvals, PDUFA Dates & Drug Alerts 2026 - MarketBeat
Polaryx’s PLX-200 granted FDA Fast Track Designation in LINCL/CLN2 - tipranks.com
Polaryx Therapeutics Inc (PLYX) 財務データ
収益
当期純利益
現金流量
EPS
0.98%
0.12%
大文字化:
|
ボリューム (24 時間):